Upgrade to SI Premium - Free Trial

Arcturus Therapeutics (ARCT)

15.29 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 8-K Arcturus Therapeutics For: Aug 25 August 25, 2026 6:05 AM - SEC Filing Arcturus Therapeutics (ARCT) Tops Q2 EPS by 21c August 6, 2026 5:14 PM - StreetInsider Form 10-Q Arcturus Therapeutics For: Jun 30 August 6, 2026 4:28 PM - SEC Filing Form 8-K Arcturus Therapeutics For: Aug 06 August 6, 2026 4:07 PM - SEC Filing Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress August 6, 2026 4:01 PM - BizWire Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 July 28, 2026 4:01 PM - BizWire Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference July 20, 2026 4:01 PM - BizWire Form 8-K Arcturus Therapeutics For: Jun 26 July 2, 2026 7:06 AM - SEC Filing Arcturus and Thermo Fisher partner on cystic fibrosis mRNA therapy July 2, 2026 7:00 AM - StreetInsider Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis July 2, 2026 7:00 AM - BizWire Freedom Broker Starts Arcturus Therapeutics (ARCT) at Buy July 2, 2026 5:37 AM - StreetInsider Full Article List